Cisplatin Resistance in Osteosarcoma: In Vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00331
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Identification and Validation of microRNAs and Their Targets Expressed in Osteosarcoma

Oncology Letters
Cancer ResearchOncology
2019English

HOXB7 Mediates Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through Involvement of DNA Damage Repair

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

MicroRNA-221 Promotes Cisplatin Resistance in Osteosarcoma Cells by Targeting PPP2R2A

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma

Anticancer Research
MedicineCancer ResearchOncology
2019English

Caffeine Citrate Enhanced Cisplatin Antitumor Effects in Osteosarcoma and Fibrosarcoma in Vitro and in Vivo

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Expression of 11 -Hydroxysteroid Dehydrogenase Enzymes in Human Osteosarcoma: Potential Role in Pathogenesis and as Targets for Treatments

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2012English

Current and Emerging Targets in Immunotherapy for Osteosarcoma

Journal of Oncology
Oncology
2019English

DNA Repair Pathways in Trypanosomatids: From DNA Repair to Drug Resistance

Microbiology and Molecular Biology Reviews
Molecular BiologyInfectious DiseasesImmunologyMicrobiologyMicrobiology
2014English

Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy